dr. seymour on the 4-year update of the murano trial in cll
Published 4 years ago • 213 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:35
dr. seymour on updated findings from the murano trial in cll
-
1:10
dr. seymour discusses rationale for murano study in cll
-
6:13
murano trial update in r/r cll
-
0:51
dr. seymour on the pfs benefit with acalabrutinib with or without obinutuzumab in cll
-
1:59
long-term follow-up results for murano trial in cll
-
1:44
dr. lamanna discusses the murano trial in cll
-
1:10
dr. seymour on shifting standards of care in cll
-
3:35
the ‘threat’ of misdiagnosis | oncologist cites link between cancer and autoimmune manifestations
-
8:20
ash 2019 interview - prof john seymour - overview of the murano study – cll/sll
-
5:03
deborah sims and john seymour – murano trial (cll)
-
1:10
impacts of the murano study for future cll treatment
-
8:04
the murano study in cll: 5 years on
-
2:25
update from murano trial: venetoclax-rituximab leads to slower clonal growth rate in cll
-
1:00
dr. seymour on the kinase selectivity of btk inhibitors in cll
-
3:12
results of the murano study for cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
2:21
updates from the murano trial
-
2:17
dr. john seymour discusses cll, depth of remission and updates from ash 2018
-
7:07
murano trial: sustained disease survival in cll following venetoclax plus rituximab